Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 40 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $7.40 million which beat the analyst consensus estimate of $6.57 million by 12.63 percent. This is a 83.62 percent increase over sales of $4.03 million the same period last year.
Strata Skin Sciences Q2 EPS $(0.03) Beats $(0.04) Estimate, Sales $7.40M Beat $6.57M Estimate
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 40 percent increase over losses of $(0.05) per share from
